GLIMEPIRIDE | A202112 | REGCON HOLDINGS LLC
Highest NADAC/Unit
$0.0464
per ea
Lowest NADAC/Unit
$0.0249
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 71921021601GLIMEPIRIDE 4 MG TABLET | $0.0464 | EA | Generic | — | 2026-10-21 |
| 71921021650GLIMEPIRIDE 4 MG TABLET | $0.0464 | EA | Generic | — | 2026-10-21 |
| 71921021501GLIMEPIRIDE 2 MG TABLET | $0.0375 | EA | Generic | — | 2026-10-21 |
| 71921021550GLIMEPIRIDE 2 MG TABLET | $0.0375 | EA | Generic | — | 2026-10-21 |
| 71921021401GLIMEPIRIDE 1 MG TABLET | $0.0249 | EA | Generic | — | 2026-10-21 |
| 71921021450GLIMEPIRIDE 1 MG TABLET | $0.0249 | EA | Generic | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.